Liposarcoma Treatment Market : Global Industry Analysis and Forecast 2016 - 2022

Liposarcoma Treatment Market : Global Industry Analysis

and Forecast 2016 - 2022

Persistence Market Research

Liposarcoma Treatment Market : Global

Industry Analysis and Forecast 2016 - 2022

Persistence Market Research

1

Liposarcoma Treatment Market : Global Industry Analysis

and Forecast 2016 - 2022

Persistence Market Research Released New Market Report on “Liposarcoma Treatment

Market : Global Industry Analysis and Forecast 2016 - 2022”.

Liposarcoma is a cancer of fat cells lying deep within the soft tissues, typically in

retroperitoneum or thighs. According to WHO, liposarcoma is the most common type of

sarcomas (cancer of soft tissue) and accounts for approximately 17-20% of all cases of

sarcoma. However, WHO classifies liposarcoma in the rare diseases as the incidence rate of

the disease is as low as 2.5 per Mn population. Liposarcoma most commonly occurs in the

middle age or adults above the age of 40 and it can be well diagnosed with the help of excision

biopsy. Liposarcoma can be of four types viz. well differentiated liposarcoma, myxoid

liposarcoma, pleomorphic liposarcoma and dedifferentiated liposarcoma. The most common

drugs used for the treatment of liposarcoma include ifosfamide and doxorubicin. Ifosfamide is

often prescribed in combination with uromitexan in order to prevent bladder irritation and internal

bleeding. Moreover, cisplatin, vincristine, etoposide, gemcitabine, docetaxel etc. can be used to

prevent the recurrence of liposarcoma.

The market for liposarcoma is highly fragmented with large number of generic manufacturers.

The global market for liposarcoma treatment is expected to grow moderately over the forecast

period owing to low incidence rate of the disease. Some other factors which are anticipated to

influence growth of global liposarcoma treatment market include lifestyle changes, incidence of

genetic disorders, growing awareness through liposarcoma genome project etc. However, high

cost of the treatment can be the major...